Guardion Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 04:06 pm EST
Share
Guardion Health Sciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 3.34 million compared to USD 2.66 million a year ago. Revenue was USD 3.34 million compared to USD 2.66 million a year ago. Net income was USD 0.372633 million compared to net loss of USD 0.822912 million a year ago. Basic earnings per share from continuing operations was USD 0.29 compared to basic loss per share from continuing operations of USD 0.67 a year ago. Diluted earnings per share from continuing operations was USD 0.29 compared to diluted loss per share from continuing operations of USD 0.67 a year ago.
For the nine months, sales was USD 9.31 million compared to USD 8.3 million a year ago. Revenue was USD 9.31 million compared to USD 8.32 million a year ago. Net loss was USD 0.266687 million compared to USD 2.47 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to USD 2.27 a year ago. Diluted loss per share from continuing operations was USD 0.21 compared to USD 2.27 a year ago.
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.